Cambridge Investment Research Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.72M | Sell |
95,487
-14,601
| -13% | -$741K | 0.01% | 1068 |
|
|
2026
Q1 | $5.87M | Sell |
110,088
-30,099
| -21% | -$1.77M | 0.02% | 879 |
|
|
2025
Q4 | $8.71M | Sell |
140,187
-2,475
| -2% | -$153K | 0.02% | 640 |
|
|
2025
Q3 | $8.57M | Sell |
142,662
-4,821
| -3% | -$295K | 0.02% | 637 |
|
|
2025
Q2 | $9.24M | Sell |
147,483
-17,942
| -11% | -$1.08M | 0.03% | 570 |
|
|
2025
Q1 | $9.96M | Sell |
165,425
-7,843
| -5% | -$487K | 0.03% | 515 |
|
|
2024
Q4 | $10.1M | Sell |
173,268
-13,489
| -7% | -$802K | 0.03% | 487 |
|
|
2024
Q3 | $11.1M | Sell |
186,757
-12,250
| -6% | -$700K | 0.04% | 461 |
|
|
2024
Q2 | $11.2M | Sell |
199,007
-10,666
| -5% | -$597K | 0.04% | 422 |
|
|
2024
Q1 | $12.3M | Sell |
209,673
-8,462
| -4% | -$478K | 0.05% | 378 |
|
|
2023
Q4 | $11.8M | Sell |
218,135
-84,039
| -28% | -$4.11M | 0.05% | 347 |
|
|
2023
Q3 | $14.7M | Sell |
302,174
-42,412
| -12% | -$2.26M | 0.07% | 276 |
|
|
2023
Q2 | $19.5M | Buy |
344,586
+33,393
| +11% | +$1.84M | 0.09% | 226 |
|
|
2023
Q1 | $16.8M | Sell |
311,193
-29,745
| -9% | -$1.58M | 0.08% | 241 |
|
|
2022
Q4 | $17.9M | Sell |
340,938
-37,300
| -10% | -$1.89M | 0.09% | 212 |
|
|
2022
Q3 | $17.8M | Sell |
378,238
-13,066
| -3% | -$678K | 0.1% | 205 |
|
|
2022
Q2 | $19.7M | Sell |
391,304
-12,450
| -3% | -$679K | 0.11% | 198 |
|
|
2022
Q1 | $24.6M | Sell |
403,754
-26,585
| -6% | -$1.58M | 0.11% | 189 |
|
|
2021
Q4 | $28.3M | Sell |
430,339
-2,203
| -0.5% | -$141K | 0.13% | 170 |
|
|
2021
Q3 | $27.2M | Sell |
432,542
-40,246
| -9% | -$2.57M | 0.13% | 163 |
|
|
2021
Q2 | $28.4M | Buy |
472,788
+450
| +0.1% | +$26K | 0.14% | 153 |
|
|
2021
Q1 | $26M | Sell |
472,338
-26,142
| -5% | -$1.45M | 0.14% | 151 |
|
|
2020
Q4 | $27.2M | Buy |
498,480
+72,240
| +17% | +$3.78M | 0.16% | 124 |
|
|
2020
Q3 | $21.3M | Buy |
426,240
+45,192
| +12% | +$2.19M | 0.14% | 154 |
|
|
2020
Q2 | $16.8M | Buy |
381,048
+141,306
| +59% | +$6.04M | 0.13% | 171 |
|
|
2020
Q1 | $9M | Sell |
239,742
-44,652
| -16% | -$1.88M | 0.09% | 226 |
|
|
2019
Q4 | $12.5M | Buy |
284,394
+24,264
| +9% | +$1.02M | 0.1% | 215 |
|
|
2019
Q3 | $10.7M | Sell |
260,130
-54,012
| -17% | -$2.21M | 0.09% | 224 |
|
|
2019
Q2 | $12.6M | Buy |
314,142
+74,928
| +31% | +$2.84M | 0.12% | 180 |
|
|
2019
Q1 | $9.23M | Buy |
239,214
+70,122
| +41% | +$2.55M | 0.09% | 219 |
|
|
2018
Q4 | $5.63M | Buy |
169,092
+15,786
| +10% | +$547K | 0.06% | 283 |
|
|
2018
Q3 | $5.81M | Buy |
153,306
+54,222
| +55% | +$1.93M | 0.06% | 327 |
|
|
2018
Q2 | $3.31M | Buy |
99,084
+14,934
| +18% | +$486K | 0.04% | 466 |
|
|
2018
Q1 | $2.6M | Sell |
84,150
-3,174
| -4% | -$97.8K | 0.03% | 540 |
|
|
2017
Q4 | $2.52M | Buy |
87,324
+23,886
| +38% | +$689K | 0.03% | 506 |
|
|
2017
Q3 | $1.77M | Sell |
63,438
-28,908
| -31% | -$800K | 0.02% | 578 |
|
|
2017
Q2 | $2.56M | Buy |
92,346
+54,576
| +144% | +$1.44M | 0.04% | 423 |
|
|
2017
Q1 | $953K | Buy |
37,770
+6,942
| +23% | +$168K | 0.02% | 746 |
|
|
2016
Q4 | $684K | Sell |
30,828
-10,512
| -25% | -$239K | 0.01% | 861 |
|
|
2016
Q3 | $1M | Sell |
41,340
-18,306
| -31% | -$435K | 0.02% | 682 |
|
|
2016
Q2 | $1.35M | Buy |
59,646
+33,990
| +132% | +$736K | 0.03% | 485 |
|
|
2016
Q1 | $524K | Buy |
25,656
+1,536
| +6% | +$29.8K | 0.01% | 868 |
|
|
2015
Q4 | $492K | Sell |
24,120
-3,714
| -13% | -$74.3K | 0.01% | 857 |
|
|
2015
Q3 | $516K | Sell |
27,834
-7,164
| -20% | -$144K | 0.01% | 745 |
|
|
2015
Q2 | $698K | Buy |
34,998
+3,984
| +13% | +$79.7K | 0.02% | 654 |
|
|
2015
Q1 | $622K | Buy |
31,014
+3,600
| +13% | +$70.3K | 0.02% | 690 |
|
|
2014
Q4 | $517K | Buy |
27,414
+1,134
| +4% | +$20.5K | 0.02% | 762 |
|
|
2014
Q3 | $435K | Buy |
26,280
+1,848
| +8% | +$31.4K | 0.01% | 892 |
|
|
2014
Q2 | $415K | Buy |
24,432
+1,434
| +6% | +$23.4K | 0.01% | 841 |
|
|
2014
Q1 | $379K | Buy |
+22,998
| New | +$369K | 0.01% | 844 |
|
Other funds holding IHI
AAS
Cambridge Investment Research Advisors's IHI Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 13% in Q2 2026, selling an estimated $741K and leaving 95,487 shares worth $4.72M. The position accounts for 0.01% of the portfolio, ranked #1068.
Cambridge Investment Research Advisors first reported a position in IHI in Q1 2014 and has held it in 50 quarters since. The position peaked at $28.4M in Q2 2021. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Cambridge Investment Research Advisors held 95,487 shares of iShares US Medical Devices ETF worth $4.72M as of Q2 2026.
- Cambridge Investment Research Advisors sold 14,601 iShares US Medical Devices ETF shares in Q2 2026, an estimated $741K.
- iShares US Medical Devices ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1068 holding.
- Cambridge Investment Research Advisors first reported a position in iShares US Medical Devices ETF in Q1 2014 and has held it in 50 quarters since.
- Cambridge Investment Research Advisors's iShares US Medical Devices ETF position peaked at $28.4M in Q2 2021.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.